Investors.soterahealth.com

Investor Relations Sotera Health

WebSotera Health Reports First-Quarter 2024 Results. Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023 Q1 2024 net income of $6 million or $0.02 per diluted share, comp ared to net income of $3 million or $0.01 per diluted share in Q1 2023 Q1 2024 Adjusted EBITDA ( 1 ) increased 13.7% to $112 million, compared to Q1 2023 Q1.

Actived: 5 days ago

URL: https://investors.soterahealth.com/

Sotera Health Reports Fourth-Quarter and Full-Year 2021 Results

WebQ4 2021 net revenues increased 11% to $241 million, compared to Q4 2020 Q4 2021 net income of $36 million or $0.13 per diluted share, compared to a net loss of $44 million or $(0.17) per diluted share in Q4 2020 Q4 2021 Adjusted EBITDA increased 10% to $125 million, compared to Q4 2020 Q4 2021

Category:  Health Go Health

Sotera Health Reports Third-Quarter and Year-to-Date 2021 …

WebThird-quarter 2021 net revenues increased 13.1% to $226 million, compared with $200 million in the same period a year ago. Third-quarter 2021 net income attributable to Sotera Health (“net income”) was $27 million, or $0.10 per diluted share, compared with net income of $0.01 million, or $0.00 per diluted share in the third quarter of 2020.

Category:  Health Go Health

Sotera Health Reports Fourth-Quarter and Full-Year 2022 Results

WebQ4 2022 net revenues increased 4% to $252 million , compared to Q4 2021 Q4 2022 net loss of $320 million or $1.14 per diluted share, which includes a $408 million legal reserve recorded in Q4 2022, compared to net income of $36 million or $0.13 per diluted share in Q4 2021 Q4 2022 Adjusted EBITDA

Category:  Health Go Health

Sotera Health Reports First-Quarter 2021 Results Sotera Health

WebFirst-quarter 2021 net revenues increased 13% to $212 million, compared with $188 million in the first-quarter a year ago. Net income attributable to Sotera Health (“net income”) was $11 million, or $0.04 per diluted share, compared with a net loss of $2 million, or $0.01 per diluted share in the first-quarter 2020.

Category:  Health Go Health

Sotera Health Reports Second-Quarter and First-Half 2021 Results

WebIncludes depreciation of Co-60 held at gamma irradiation sites. Represents non-cash share-based compensation expense. Represents the effects of (i) fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries’ functional currencies, and (ii) non …

Category:  Health Go Health

Sotera Health Reports Third-Quarter and Year-to-Date 2022 …

WebThird-quarter 2022 net revenues increased 10.0% to $249 million, compared with $226 million in the same period a year ago. Net revenues increased 13.2% on a constant currency basis. Third-quarter 2022 net income attributable to Sotera Health (“net income”) was $25 million, or $0.09 per diluted share, compared with net income of $27 million

Category:  Health Go Health

Jonathan Lyons Management Sotera Health

WebJonathan (Jon) Lyons has served as senior vice president and chief financial officer of Sotera Health since June 2023. Prior to joining Sotera Health, Mr. Lyons was most recently the vice president, corporate FP&A for Owens Corning. Prior to this role, Mr. Lyons was vice president and finance leader for Owens Corning’s Insulation business and

Category:  Health Go Health

Sotera Health Reports First-Quarter 2024 Results Sotera Health

WebNelson Labs. For first-quarter 2024, net revenues were $58 million, an increase of 10.8% compared to the first quarter a year ago. Segment income increased 8.8% to $15 million. Net revenue and segment income growth for the first-quarter 2024 were primarily driven by volume and mix improvements as well as favorable pricing.

Category:  Health Go Health

Sotera Health Reports Third-Quarter and Year-to-Date 2023 …

WebThird-quarter 2023 net revenues increased 5.8% to $263 million, compared with $249 million in the third-quarter 2022. Net loss was $14 million, or $0.05 per diluted share, including a previously disclosed legal settlement of $35 million. This compares with net income of $25 million, or $0.09 per diluted share in the third-quarter of 2022.

Category:  Health Go Health

Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results

Web2023 net revenues increased 4.5% to $1.05 billion, compared to 2022; 2023 net income of $51 million or $0.18 per diluted share; 2023 Adjusted EBITDA (1) increased 4.3% to $528 million; 2023 Adjusted EPS (1) decreased $0.15 to $0.81 per diluted share; Full-year 2024 outlook of 4.0% - 6.0% growth for Net Revenues and Adjusted EBITDA; …

Category:  Health Go Health

News Sotera Health

WebCLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share. 27 Feb, '2024. Sotera Health Announces Secondary

Category:  Health Go Health

News Release Details

WebAcquisition strengthens Nelson Labs’ outsourced testing capabilities to better serve the pharmaceutical and medical device industries. CLEVELAND, Ohio – August 8, 2018 – Sotera Health, the world’s leading, fully integrated protector of global health, announced today that it has acquired New Jersey-based Gibraltar Laboratories. This …

Category:  Medical Go Health

Sotera Health Reports Second-Quarter and First-Half 2022 Results

WebSotera Health Reports Second-Quarter and First-Half 2022 Results. Aug 4, 2022. Download PDF. Q2 2022 net revenues of $267 million increased 6%, compared to Q2 2021. Q2 2022 net income of $30 million or $0.11 per diluted share, compared to net income of $43 million or $0.15 per diluted share in Q2 2021. Q2 2022 Adjusted EBITDA of $136 …

Category:  Health Go Health

Sotera Health Appoints Karen Flynn to Board of Directors Sotera …

WebCLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Karen Flynn as a new independent director to its Board.

Category:  Health Go Health

News Release Details

WebNew Sotera Health Academy offers curated content created by industry experts from Nelson Labs, Sterigenics, and Nordion to support MedTech and Pharmaceutical Customers CLEVELAND, March 03, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical

Category:  Health Go Health

Sotera Health Announces Fourth-Quarter and Full-Year 2023 …

WebCLEVELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2023 …

Category:  Health Go Health

Our Commitment to We are a global leader in our markets

WebSotera Health Company (NASDAQ: SHC) is a leading global. provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. The name Sotera Health was inspired by Soteria, the Greek goddess of safety, and reflects the Company’s unwavering commitment to its mission, Safeguarding

Category:  Health Go Health

Sotera Health Announces Pricing of Secondary Offering Sotera …

WebCLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share. All 25,000,000 shares are being offered by selling

Category:  Health Go Health